These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 11873307

  • 1. [Precancerous lesion of the endometrium and endometrial morphology in patients with tamoxifen therapy].
    Schmidt D, Horn LC.
    Zentralbl Gynakol; 2002 Jan; 124(1):3-9. PubMed ID: 11873307
    [Abstract] [Full Text] [Related]

  • 2. [Morphologic endometrium changes with tamoxifen].
    Dallenbach-Hellweg G, Hahn U, Schmidt D.
    Zentralbl Gynakol; 1996 Jan; 118(6):365-9. PubMed ID: 8768015
    [Abstract] [Full Text] [Related]

  • 3. Tamoxifen and endometrial cancer.
    Segna RA, Dottino PR, Deligdisch L, Cohen CJ.
    Mt Sinai J Med; 1992 Oct; 59(5):416-8. PubMed ID: 1435840
    [Abstract] [Full Text] [Related]

  • 4. [Dualistic model of molecular pathogenesis in endometrial carcinoma].
    Lax SF.
    Zentralbl Gynakol; 2002 Jan; 124(1):10-6. PubMed ID: 11873308
    [Abstract] [Full Text] [Related]

  • 5. Histopathology of endometrial hyperplasia and endometrial carcinoma: an update.
    Horn LC, Meinel A, Handzel R, Einenkel J.
    Ann Diagn Pathol; 2007 Aug; 11(4):297-311. PubMed ID: 17630117
    [Abstract] [Full Text] [Related]

  • 6. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen.
    Lahti E, Blanco G, Kauppila A, Apaja-Sarkkinen M, Taskinen PJ, Laatikainen T.
    Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):660-4. PubMed ID: 8469450
    [Abstract] [Full Text] [Related]

  • 7. Tamoxifen and the endometrium: review of 102 cases and comparison with HRT-related and non-HRT-related endometrial pathology.
    Kennedy MM, Baigrie CF, Manek S.
    Int J Gynecol Pathol; 1999 Apr; 18(2):130-7. PubMed ID: 10202670
    [Abstract] [Full Text] [Related]

  • 8. Histopathology of functional and neoplastic changes in cervix and endometrium.
    Dallenbach-Hellweg G.
    Verh Dtsch Ges Pathol; 1997 Apr; 81():240-4. PubMed ID: 9474876
    [Abstract] [Full Text] [Related]

  • 9. Endometrial polyps: a comparison study of patients receiving tamoxifen with two control groups.
    Schlesinger C, Kamoi S, Ascher SM, Kendell M, Lage JM, Silverberg SG.
    Int J Gynecol Pathol; 1998 Oct; 17(4):302-11. PubMed ID: 9785130
    [Abstract] [Full Text] [Related]

  • 10. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer.
    Deligdisch L, Kalir T, Cohen CJ, de Latour M, Le Bouedec G, Penault-Llorca F.
    Gynecol Oncol; 2000 Aug; 78(2):181-6. PubMed ID: 10926800
    [Abstract] [Full Text] [Related]

  • 11. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
    Semiglazov VF, Maksimov SIa, Bulgatova EA, Meshkova IE, Chepik OF, Berstein LM.
    Vopr Onkol; 2003 Aug; 49(2):198-204. PubMed ID: 12785205
    [Abstract] [Full Text] [Related]

  • 12. [Endometrial cancers arising in polyps associated with tamoxifen use].
    Mbatsogo BA, Le Bouëdec G, Michy T, Bourdel N, Fouilloux G, Dauplat J.
    Gynecol Obstet Fertil; 2005 Dec; 33(12):975-9. PubMed ID: 16321556
    [Abstract] [Full Text] [Related]

  • 13. Effects of hormone therapy on the endometrium.
    Deligdisch L.
    Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860
    [Abstract] [Full Text] [Related]

  • 14. [Pathology of the endometrium in breast cancer patients treated with tamoxifen (nolvadex)].
    Ivanova V, Karaivanov M, Marinov E, Gorchev G, Velkova A, Khristova P.
    Akush Ginekol (Sofiia); 2003 Jan; 42(5):3-8. PubMed ID: 14682005
    [Abstract] [Full Text] [Related]

  • 15. Endometrial pathologies associated with postmenopausal tamoxifen treatment.
    Cohen I.
    Gynecol Oncol; 2004 Aug; 94(2):256-66. PubMed ID: 15297160
    [Abstract] [Full Text] [Related]

  • 16. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
    Hauth E, Libera H, Kimmig R, Forsting M.
    Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
    [Abstract] [Full Text] [Related]

  • 17. Endometrial changes with chronic tamoxifen use.
    Loret de Mola JR.
    Curr Opin Obstet Gynecol; 1997 Jun; 9(3):160-4. PubMed ID: 9263698
    [Abstract] [Full Text] [Related]

  • 18. [Role of steroid hormones and related biological substances in the etiology of endometrial carcinomas].
    Lang-Avérous G, Rupp K, Wehner H, Dallenbach-Hellweg G.
    Verh Dtsch Ges Pathol; 1991 Jun; 75():366-9. PubMed ID: 1724843
    [Abstract] [Full Text] [Related]

  • 19. Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis.
    Wu H, Chen Y, Liang J, Shi B, Wu G, Zhang Y, Wang D, Li R, Yi X, Zhang H, Sun L, Shang Y.
    Nature; 2005 Dec 15; 438(7070):981-7. PubMed ID: 16355216
    [Abstract] [Full Text] [Related]

  • 20. [Postmenopausal hemorrhage and endometrial cancer in tamoxifen therapy].
    Krause A, Gerber B.
    Zentralbl Gynakol; 1994 Dec 15; 116(1):44-7. PubMed ID: 8147180
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.